NCT06257277View on ClinicalTrials.gov

An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

July 8, 2024

Primary Completion Date

January 29, 2025

Study Completion Date

May 26, 2025

Conditions
Contrast Enhancement in Magnetic Resonance Imaging
Interventions
DRUG

GBCAs

GBCAs are given per routine clinical practice.

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT06257277 - An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India | Biotech Hunter | Biotech Hunter